AXS-07

· Axsome Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AXS-07, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) [Phase 3]

See pricing